author-photo

Karen Sims

Bristol-Myers Squibb

21

Papers

516

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects

2018 Drugs in R & D
Show All
- Source
- Cite
- Save
Citations (10)
CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects

2017 The Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (18)
NS5A Sequence Heterogeneity and Mechanisms of Daclatasvir Resistance in Hepatitis C Virus Genotype 4 Infection

2016 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (25)
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients

2016 Liver International
Show All
- Source
- Cite
- Save
Citations (20)
A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection

2015 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (46)
P0790 : The effect of renal impairment on multiple-dose pharmacokinetics of the fixed-dose combination of daclatasvir/asunaprevir/beclabuvir

2015 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (5)
Tu1011 The Effect of Renal Impairment on Multiple-Dose Pharmacokinetics of the Fixed-Dose Combination of Daclatasvir/Asunaprevir/Beclabuvir

2015 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
P1156 DACLATASVIR, ASUNAPREVIR, AND BMS-791325 IN A FIXED-DOSE COMBINATION: A PHASE 1 BIOAVAILABILITY STUDY IN HEALTHY VOLUNTEERS

2014 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (1)
P1163 ALL-ORAL THERAPY WITH DACLATASVIR IN COMBINATION WITH ASUNAPREVIR AND BMS-791325 FOR TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE 4 INFECTION

2014 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (11)
Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

2014 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (186)